Burkholderia cepacia complex bacteria:: opportunistic pathogens with important natural biology

被引:304
作者
Mahenthiralingam, E. [1 ]
Baldwin, A. [2 ]
Dowson, C. G. [2 ]
机构
[1] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, Wales
[2] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England
基金
英国惠康基金;
关键词
Burkholderia; cystic fibrosis; environmental microbiology; molecular epidemiology; pathogenesis;
D O I
10.1111/j.1365-2672.2007.03706.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Interaction with plants around their roots and foliage forms the natural habitat for a wide range of gram-negative bacteria such as Burkholderia, Pseudomonas and Ralstonia. During these interactions many of these bacteria facilitate highly beneficial processes such as the breakdown of pollutants or enhancement of crop growth. All these bacterial species are also capable of causing opportunistic infections in vulnerable individuals, especially people with cystic fibrosis (CF). Here we will review the current understanding of the Burkholderia cepacia complex (Bcc) as a group of model opportunistic pathogens, contrasting their clinical epidemiology with their ecological importance. Currently, the B. cepacia complex is composed of nine formally named species groups which are all difficult to identify using phenotypic methods. Genetic methods such as 16S rRNA and recA gene sequence analysis have proven useful for Bcc species identification. Multilocus sequence typing (MLST) is also emerging as a very useful tool for both Bcc strain and species identification. Historically, Burkholderia cenocepacia was the most dominant Bcc pathogen in CF, however, probably as a result of strict infection control practices introduced to control the spread of this species, its prevalence has been reduced. Burkholderia multivorans is the now the most dominant Bcc infection encountered in the UK CF population, a changing epidemiology that also appears to be occurring in the US CF population. The distribution of Bcc species residing in the natural environment may vary considerably with the type of environment examined. Clonally identical Bcc strains have been found to occur in the natural environment and cause infection. The contamination of medical devices, disinfectants and pharmaceutical formulations has also been directly linked to several outbreaks of infection. In the last 10 years considerable progress has been made in understanding the natural biology and clinical infections caused by this fascinating group of bacteria.
引用
收藏
页码:1539 / 1551
页数:13
相关论文
共 71 条
[1]   Burkholderia cepacia complex infection in Italian patients with cystic fibrosis:: Prevalence, epidemiology, and genomovar status [J].
Agodi, A ;
Mahenthiralingam, E ;
Barchitta, M ;
Gianninò, V ;
Sciacca, A ;
Stefani, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) :2891-2896
[2]   Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex [J].
Baldwin, A ;
Mahenthiralingam, E ;
Thickett, KM ;
Honeybourne, D ;
Maiden, MCJ ;
Govan, JR ;
Speert, DP ;
LiPuma, JJ ;
Vandamme, P ;
Dowson, CG .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) :4665-4673
[3]   Environmental Burkholderia cepacia complex isolates in human infections [J].
Baldwin, Adam ;
Mahenthiralingam, Eshwar ;
Drevinek, Pavel ;
Vandamme, Peter ;
Govan, John R. ;
Waine, David J. ;
LiPuma, John J. ;
Chiarini, Luigi ;
Dalmastri, Claudia ;
Henry, Deborah A. ;
Speert, David P. ;
Honeybourne, David ;
Maiden, Martin C. J. ;
Dowson, Chris G. .
EMERGING INFECTIOUS DISEASES, 2007, 13 (03) :458-461
[4]   Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis [J].
Biddick, R ;
Spilker, T ;
Martin, A ;
LiPuma, JJ .
FEMS MICROBIOLOGY LETTERS, 2003, 228 (01) :57-62
[5]   Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples [J].
Brown, A. R. ;
Govan, J. R. W. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (06) :1920-1926
[6]  
BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115
[7]   Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis [J].
Chen, JS ;
Witzmann, KA ;
Spilker, T ;
Fink, RJ ;
LiPuma, JJ .
JOURNAL OF PEDIATRICS, 2001, 139 (05) :643-649
[8]   Burkholderia cepacia complex species:: health hazards and biotechnological potential [J].
Chiarini, Luigi ;
Bevivino, Annamaria ;
Dalmastri, Claudia ;
Tabacchioni, Silvia ;
Visca, Paolo .
TRENDS IN MICROBIOLOGY, 2006, 14 (06) :277-286
[9]   Burkholderia ambifaria sp nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates [J].
Coenye, T ;
Mahenthiralingam, E ;
Henry, D ;
LiPuma, JJ ;
Laevens, S ;
Gillis, M ;
Speert, DP ;
Vandamme, P .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2001, 51 :1481-1490
[10]   Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe [J].
Coenye, T ;
Spilker, T ;
Van Schoor, A ;
LiPuma, JJ ;
Vandamme, P .
THORAX, 2004, 59 (11) :952-954